Metabolic dysfunction-associated fatty liver disease is associated with the presence of coronary atherosclerotic plaques and plaque burden.
Cai X, Su X, Zhang Y, Wang S, Pan Y, Jin A, Jing J, Sun J, Mei L, Meng X, Li S, Xia Z, Li Y, Liu Z, Wang Y, He Y, Wei T.
Cai X, et al. Among authors: mei l.
Hellenic J Cardiol. 2024 Jun 11:S1109-9666(24)00126-X. doi: 10.1016/j.hjc.2024.06.002. Online ahead of print.
Hellenic J Cardiol. 2024.
PMID: 38871181
Free article.